These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1689891)

  • 1. Pathologic observations in human allograft recipients treated with FK 506.
    Demetris AJ; Fung JJ; Todo S; Banner B; Zerbe T; Sysyn G; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):25-34. PubMed ID: 1689891
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
    Fung JJ; Todo S; Jain A; McCauley J; Alessiani M; Scotti C; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):6-12. PubMed ID: 1689901
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine.
    Demetris AJ; Banner B; Fung J; Shapiro R; Jordan M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):944-6. PubMed ID: 1703360
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
    Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
    [No Abstract]   [Full Text] [Related]  

  • 5. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
    Van Thiel DH; Iqbal M; Jain A; Fung J; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):37-40. PubMed ID: 1689893
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic allograft rejection.
    Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen-Sokolowski A; Koskinen P; Ustinov J; Lautenschlager I; Taskinen E
    Immunol Rev; 1993 Aug; 134():33-81. PubMed ID: 8225374
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver, kidney, and thoracic organ transplantation under FK 506.
    Todo S; Fung JJ; Starzl TE; Tzakis A; Demetris AJ; Kormos R; Jain A; Alessiani M; Takaya S; Shapiro R
    Ann Surg; 1990 Sep; 212(3):295-305; discussion 306-7. PubMed ID: 1697743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of FK 506 on renal function after liver transplantation.
    McCauley J; Fung J; Jain A; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):17-20. PubMed ID: 1689887
    [No Abstract]   [Full Text] [Related]  

  • 11. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
    Takaya S; Duquesnoy R; Iwaki Y; Demetris J; Yagihashi A; Bronsther O; Iwatsuki S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):396-9. PubMed ID: 1703691
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract]   [Full Text] [Related]  

  • 14. The question of FK 506 nephrotoxicity after liver transplantation.
    McCauley J; Takaya S; Fung J; Tzakis A; Abu-Elmagd K; Jain A; Todo S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1444-7. PubMed ID: 1703344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE; Wu J; Shorthouse R
    Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.
    Zeevi A; Eiras G; Kaufman C; Alessiani M; Demetris AJ; Abu-Elmagd K; Jain A; Warty V; Venkataramanan R; Burckart G
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1406-8. PubMed ID: 1703341
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The side effects of FK 506 in humans.
    Shapiro R; Fung JJ; Jain AB; Parks P; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):35-6. PubMed ID: 1689892
    [No Abstract]   [Full Text] [Related]  

  • 20. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.
    Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T
    Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.